The arteriovenous fistula (AVF) was first described and used as a reliable form of
hemodialysis (HD) vascular access (VA) by Brescia et al.(1) in 1966. Improvements in …

English language citations reporting complications of arteriovenous access for hemodialysis
are critically reviewed and discussed. Venous hypertension, arterial steal syndrome, and …

This paper is part of the Clinical Trial Endpoints for Dialysis Vascular Access Project of the
American Society of Nephrology Kidney Health Initiative. The purpose of this project is to …

OBJECTIVE. In the United States, more than 250,000 patients with end-stage renal disease
are dialyzed through arteriovenous fistulas (AVFs). The three most common AVFs are the …

When the evidence of literature is weak, conflicting, or contradictory, consensus for the
parameter is reached by a minimum of 12 Standards of Practice Committee members using …

BACKGROUND: Early recurrent stenosis of the cephalic arch in autogenous arteriovenous
access for hemodialysis is a common problem that requires stenting to prevent thrombosis …

Abstract The Fistula First Initiative has strongly encouraged nephrologists, vascular access
surgeons, and dialysis units in the United States to make valiant efforts to increase fistula …

PURPOSE: To describe the number and type of percutaneous interventions required to
promote maturation and maintain patency of hemodialysis fistulas MATERIALS AND …

The role of paclitaxel-coated balloons has been established in the coronary and peripheral
arterial circulations with recent interest in the use of paclitaxel-coated balloons to improve …

Background: Endovascular treatment of autogenous arteriovenous haemodialysis fistula
stenosis has high reintervention rates. We investigate the effect of drug-eluting balloons in …